Naomi Fried, Boston Children’s Hospital chief innovation officer, today said she is stepping down from her position to join Biogen Idec as vice president of medical information, innovation and external partnerships.
Fried told colleagues of the move to the Cambridge-based pharma company in an internal email today, saying it was a “hard decision” to leave the hospital but that the job with Biogen “was too good of an opportunity for me to pass up.”
“I feel grateful to all of the people at Boston Children’s who supported me and the work of my Innovation Acceleration Program over the past 4.5 years,” she wrote. “One of the best parts of my job was working with the immensely talented and dedicated doctors and nurses who are continuously innovating and striving to improve care delivery. I have loved being a part of their amazing work and feel privileged to have been able to support their efforts.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In her new role, Fried said she will “manage a variety of existing capabilities as well as building a new innovation program for them,” with a focus on Multiple Sclerosis and Hemophilia patients that Biogen services. Part of her new job will include finding new ways to connect Biogen to both patients and physicians.
